Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nels Nielson"'
Autor:
Kanam Malhotra, Thomas Thisted, Arnab Mukherjee, Zuzana Biesova, Yuliya Kleschenko, Zhi-Gang Jiang, Anokhi Cifuentes, Nadthakarn Boland, Nels Nielson, Edward van der Horst
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/a7171874660f48d1bde798669b971c40
Autor:
Philipp Janesch, Harald Rouha, Adriana Badarau, Lukas Stulik, Irina Mirkina, Marisa Caccamo, Katharina Havlicek, Barbara Maierhofer, Susanne Weber, Karin Groß, Jacqueline Steinhäuser, Manuel Zerbs, Cecilia Varga, Ivana Dolezilkova, Sabine Maier, Gerhild Zauner, Nels Nielson, Christine A. Power, Eszter Nagy
Publikováno v:
Virulence, Vol 9, Iss 1, Pp 1521-1538 (2018)
Streptococcus pneumoniae isolates express up to three neuraminidases (sialidases), NanA, NanB and NanC, all of which cleave the terminal sialic acid of glycan-structures that decorate host cell surfaces. Most research has focused on the role of NanA
Externí odkaz:
https://doaj.org/article/3d6e41b7d535455faecc94e43c18d40e
Autor:
Lukas Stulik, Nels Nielson, Marisa Caccamo, Eszter Nagy, Christine A. Power, Ivana Dolezilkova, Adriana Badarau, Karin Groß, Gerhild Zauner, Irina Mirkina, Philipp Janesch, Sabine Maier, Manuel Zerbs, Jacqueline Steinhäuser, Cecília Varga, Katharina Havlicek, Susanne Maria Weber, Barbara Maierhofer, Harald Rouha
Publikováno v:
Virulence
Virulence, Vol 9, Iss 1, Pp 1521-1538 (2018)
Virulence, Vol 9, Iss 1, Pp 1521-1538 (2018)
Streptococcus pneumoniae isolates express up to three neuraminidases (sialidases), NanA, NanB and NanC, all of which cleave the terminal sialic acid of glycan-structures that decorate host cell surfaces. Most research has focused on the role of NanA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eedca08714bb46ebf828909b0dc2395
Autor:
Zuzana Biesova, Yuliya Kleschenko, Thomas Thisted, Anokhi Cifuentes, Kanam Malhotra, Nels Nielson, Zhi-Gang Jiang, Arnab Mukherjee, Nadthakarn Boland, Edward van der Horst
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundImmunotherapies, especially immune checkpoint inhibitors, have become a cornerstone of cancer treatment. Remarkable clinical responses have been observed blocking the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3f3e862318347b83ba1f21092201688
https://doi.org/10.1136/jitc-2021-sitc2021.228
https://doi.org/10.1136/jitc-2021-sitc2021.228
Autor:
Lukas Stulik, Irina Mirkina, Nels Nielson, Derek T. Logan, Astrid Teubenbacher, Stefan Malafa, M. Welin, Zoltán Magyarics, Adriana Badarau, Laura M. Walker, Eszter Nagy, Karin Gross, Srijib Banerjee, Susanne Maria Weber, Clara Pleban, Barbara Maierhofer, Michael B. Battles, Ivana Dolezilkova, Michaela Jägerhofer, Gerhild Zauner, Harald Rouha
Publikováno v:
mAbs
LukGH (LukAB) is a potent leukocidin of Staphylococcus aureus that lyses human phagocytic cells and is thought to contribute to immune evasion. Unlike the other bi-component leukocidins of S. aureus, LukGH forms a heterodimer before binding to its re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac0627ccf7dc1a473c2e4d62e4440a10
https://pubmed.ncbi.nlm.nih.gov/27467113
https://pubmed.ncbi.nlm.nih.gov/27467113